Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 143
  • Home
  • Print this page
  • Email this page

Previous article Browse articles Next article 
J Res Med Sci 2018,  23:21

Responding to the challenge of antibiotic resistance: World Health Organization

1 Department of Community Medicine, Member of the Medical Education Unit and Medical Research Unit, Chennai, Tamil Nadu, India
2 Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Chennai, Tamil Nadu, India

Date of Web Publication27-Mar-2018

Correspondence Address:
Dr. Saurabh R Shrivastava
Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, 3rd Floor, Ammapettai Village, Thiruporur - Guduvanchery Main Road, Sembakkam Post, Kancheepuram - 603 108, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1735-1995.228593

Rights and Permissions

How to cite this article:
Shrivastava SR, Shrivastava PS, Ramasamy J. Responding to the challenge of antibiotic resistance: World Health Organization. J Res Med Sci 2018;23:21

How to cite this URL:
Shrivastava SR, Shrivastava PS, Ramasamy J. Responding to the challenge of antibiotic resistance: World Health Organization. J Res Med Sci [serial online] 2018 [cited 2022 Oct 7];23:21. Available from: https://www.jmsjournal.net/text.asp?2018/23/1/21/228593


Globally, antibiotic resistance has emerged as one of the biggest threats that can affect anyone, irrespective of their age, gender, race, geographical region, etc., and has severely compromised the ability to treat communicable diseases.[1] Further, antibiotic resistance has seriously raised questions toward the utility of other achievements in the health sector such as organ transplant or chemotherapy for malignancies.[2] The problem of antibiotic resistance is increasing at an exponential rate in different parts of the globe, and in the absence of immediate corrective measures, the world is heading toward a postantibiotic era, in which common infections/trivial injuries can once again result in fatality.[1],[3]

Even though it is known that antibiotic resistance precipitates naturally, nevertheless, the misuse of antibiotics in both humans as well as animals is providing impetus for its quick rise globally.[2],[4] Further, a wide range of factors, such as over-the-counter sale of antibiotics without prescription, no comprehensive universal mechanism to prohibit the sale of antibiotics over the internet, the absence of standardized treatment guidelines for all infectious disease owing to which antibiotics are either overprescribed or overconsumed, misuse of antibiotics, poor infection, and control measures, have played a significant role in the augmentation of the problem.[1],[2],[5]

Despite the absence of a universal surveillance mechanism to obtain the precise magnitude of the problem, the estimate from the European Union revealed quite alarming death rates, enormous financial expenditure on health, and a reduction in productivity each year.[2] This is predominantly because of the compulsion to use second-line drugs (as the first-line drugs are ineffective) that are more expensive, longer treatment schedule, more incidence of adverse drug effects or disease-associated complications, and longer stay in hospital and thus more risk of nosocomial infections, all of which together have increased the burden on families and societies.[3],[4],[5],[6]

Acknowledging the scale of the problem, universal distribution, and significant impact on health, it is crucial to plan and implement measures to tackle the menace of antibiotic resistance.[1],[5] In fact, the World Health Organization has developed a global action plan on how to combat antibiotic resistance, with an ultimate aim to ensure prevention of communicable diseases, and continuation of effective treatment with the help of safe medicines in a standardized manner for as long as possible.[2] However, if the international stakeholders practically aim to restrict the spread of antibiotic resistance, there is a significant need to improve the awareness and understanding about antibiotic resistance among both the general population and health professionals, strengthen surveillance and research activities, implement measures to reduce the incidence of infection, standardize the use of drugs, continue financial support to effectively respond to the problem, and involve all the stakeholders (viz., the general public, health workers, pharmacists, policymakers, the agricultural sector, the healthcare industry).[2],[4],[5]

To conclude, if the world really wants to respond to the antibiotic resistance, there is an indispensable need to modify the way in which antibiotics are either prescribed or used. Further, none of the achieved gains can be sustainable, if we fail to change the behavior of people to contain the spread of infections.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Bond C. Antibiotic resistance: Turning back the tide. Int J Pharm Pract 2015;23:307-8.  Back to cited text no. 1
World Health Organization. Antimicrobial Resistance: Global Report on Surveillance 2014. Geneva: WHO Press; 2014. p. 1-19.  Back to cited text no. 2
Rajabi M, Abdar ME, Rafiei H, Aflatoonia MR, Abdar ZE. Nosocomial infections and epidemiology of antibiotic resistance in teaching hospitals in south east of Iran. Glob J Health Sci 2015;8:50327.  Back to cited text no. 3
World Health Organization. Antibiotic Resistance — Fact Sheet; 2015. Available from: http://who.int/mediacentre/factsheets/antibiotic-resistance/en/. [Last accessed on 2015 Oct 19].  Back to cited text no. 4
Parsons M. Antibiotic resistance: Clearer guidelines needed. Br Dent J 2015;219:246.  Back to cited text no. 5
Chattopadhyay MK, Chakraborty R, Grossart HP, Reddy GS, Jagannadham MV. Antibiotic resistance of bacteria. Biomed Res Int 2015;2015:501658.  Back to cited text no. 6

This article has been cited by
1 Synthetic antibacterial discovery of symbah-1, a macrocyclic ß-hairpin peptide antibiotic
Justin R. Randall, Gillian Davidson, Renee M. Fleeman, Santos A. Acosta, Ian M. Riddington, T. Jeffrey Cole, Cory D. DuPai, Bryan W. Davies
iScience. 2022; 25(1): 103611
[Pubmed] | [DOI]
2 Phage Therapy for Antibiotic-Resistant Bacterial Infections
Graham F. Hatfull, Rebekah M. Dedrick, Robert T. Schooley
Annual Review of Medicine. 2022; 73(1): 197
[Pubmed] | [DOI]
3 Bacteriophages: Potential Biocontrol Agents and Treatment Options for Bacterial Pathogens
N. Harshitha, Aishwarya Rajasekhar, Suman Saurabh, Rohit Sonalkar, M. Tejashwini, Susweta Das Mitra
Clinical Microbiology Newsletter. 2022; 44(5): 41
[Pubmed] | [DOI]
4 Tracking the Origins of Pseudomonas aeruginosa Phylogroups by Diversity and Evolutionary Analysis of Important Pathogenic Marker Genes
Sara E. Quiroz-Morales, Selene García-Reyes, Gabriel Yaxal Ponce-Soto, Luis Servín-González, Gloria Soberón-Chávez
Diversity. 2022; 14(5): 345
[Pubmed] | [DOI]
5 Pathogenic Spectrum and Resistance Pattern of Bloodstream Infections Isolated from Postpartum Women: A Multicenter Retrospective Study
Qin Zou,Hua Zou,Yan Shen,Lang Yu,Wei Zhou,Chenglin Sheng,Ang Liao,Chunli Li
Infection and Drug Resistance. 2021; Volume 14: 2387
[Pubmed] | [DOI]
6 Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis
Praveen Kumar Jadi,Prerana Sharma,Bharathi Bhogapurapu,Sanhita Roy
Frontiers in Chemistry. 2021; 9
[Pubmed] | [DOI]
7 Microbes Go to School: Using Microbiology and Service-Learning to Increase Science Awareness and Fostering the Relationship Between Universities and the General Public
Mathilda Fatton,Arthur Schneiter,Miriam Allisiardi,Lola Hänni,Gilles Hauser,Yazalde Gonçalves-Fernandes,Alice Pessina,Marie-Lou Pijnenburg,Clément Vaudroz,Andrea Bshary,Saskia Bindschedler,Pilar Junier
Frontiers in Education. 2021; 6
[Pubmed] | [DOI]
8 Impact of O-Acetylation on S. flexneri 1b and 2a O-Antigen Immunogenicity in Mice
Vanessa Arato, Davide Oldrini, Luisa Massai, Gianmarco Gasperini, Francesca Necchi, Francesca Micoli
Microorganisms. 2021; 9(11): 2360
[Pubmed] | [DOI]
9 Biofilm Production Ability, Virulence and Antimicrobial Resistance Genes in Staphylococcus aureus from Various Veterinary Hospitals
Lin Chen,Zi-Yun Tang,Shi-Yun Cui,Zhen-Bao Ma,Hua Deng,Wei-Li Kong,Li-Wen Yang,Chao Lin,Wen-Guang Xiong,Zhen-Ling Zeng
Pathogens. 2020; 9(4): 264
[Pubmed] | [DOI]
10 Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay
Giuseppe Lippi,Gian Luca Salvagno,Matteo Gelati,Mairi Pucci,Davide Demonte,Diego Faggian,Mario Plebani
Diagnostics. 2020; 10(3): 128
[Pubmed] | [DOI]
11 Wastewater treatment plant workers’ exposure and methods for risk evaluation of their exposure
Rui Lu,Margit W. Frederiksen,Katrine Uhrbrand,Yanpeng Li,Claus Østergaard,Anne Mette Madsen
Ecotoxicology and Environmental Safety. 2020; 205: 111365
[Pubmed] | [DOI]
12 Preventing the emergence of antimicrobial resistance among food-producing animals
SaurabhRamBihariLal Shrivastava,PrateekSaurabh Shrivastava
International Archives of Health Sciences. 2019; 6(3): 149
[Pubmed] | [DOI]


Previous article  Next article
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded309    
    Comments [Add]    
    Cited by others 12    

Recommend this journal